We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Iron Deficiency Anemia Associated with Hearing Loss

By LabMedica International staff writers
Posted on 10 Jan 2017
In a new study assessing medical records of over 300,000 adults, researchers found a significant positive association between iron deficiency anemia (IDA) and hearing loss, including sensorineural hearing loss (SNHL).

Because IDA is a common and easily correctable condition, further understanding of the association between IDA and all types of hearing loss may help to open new possibilities for early identification and appropriate treatment. More...
For this study, Kathleen M. Schieffer, BS, of Pennsylvania State University College of Medicine (Hershey, PA, USA), and colleagues investigated the potential association using data obtained from deidentified electronic medical records from the Penn State Milton S. Hershey Medical Center (Hershey, PA, USA). IDA was determined by low hemoglobin and ferritin levels for age and sex in 305,339 adults ages 21-90 years.

Of the patients in the study population, 43% were men; average age was 50 years. There was a 0.7% prevalence of IDA and a 1.6% prevalence of “combined hearing loss” (defined as any combination of: conductive hearing loss [hearing loss due to problems with the bones of the middle ear], sensorineural hearing loss [SNHL; when there is damage to the cochlea or to the nerve pathways from the inner ear to the brain], deafness, and unspecified hearing loss).

Both sensorineural hearing loss (present in 1.1% of individuals with IDA) and combined hearing loss (present in 3.4%) were significantly associated with IDA. Analysis confirmed increased odds of SNHL and combined hearing loss among adults with IDA.

“An association exists between IDA in adults and hearing loss. The next steps are to better understand this correlation and whether promptly diagnosing and treating IDA may positively affect the overall health status of adults with hearing loss,” the researchers wrote.

The study, by Schieffer KM et al, was published online December 29, 2016, in the journal JAMA Otolaryngology–Head & Neck Surgery.

Related Links:
Pennsylvania State University College of Medicine


Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.